ENTRY       D00892                      Drug
NAME        Fluvastatin sodium (JAN/USP);
            Lescol (TN)
PRODUCT     LESCOL (Novartis Pharmaceuticals Corporation)
  GENERIC   FLUVASTATIN (Bryant Ranch Prepack)
            FLUVASTATIN (Bryant Ranch Prepack)
            FLUVASTATIN (Teva Pharmaceuticals USA)
            FLUVASTATIN SODIUM (Lannett Company)
            FLUVASTATIN SODIUM (Mylan Pharmaceuticals)
            FLUVASTATIN SODIUM (Sandoz)
            FLUVASTATIN SODIUM (Teva Pharmaceuticals USA)
FORMULA     C24H25FNO4. Na
EXACT_MASS  433.1665
MOL_WEIGHT  433.4478
CLASS       Hypolipidemic agent
             DG01946  Hypolipidemic agent
              DG01660  HMG-CoA reductase inhibitor
            Metabolizing enzyme substrate
             DG01642  CYP2C9 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG01643  CYP2C9 inhibitor
            Transporter substrate
             DG02856  SLCO1B1 substrate
            Transporter inhibitor
             DG02882  ABCB11 inhibitor
REMARK      Therapeutic category: 2189
            ATC code: C10AA04
            Chemical structure group: DG00354
            Product (DG00354): D00892<JP/US>
EFFICACY    Antihyperlipidemic, HMG-CoA reductase inhibitor
  DISEASE   Hypercholesterolemia (Heterozygous familial) [DS:H00155]
            Mixed dyslipidemia [DS:H01635]
TARGET      HMGCR [HSA:3156] [KO:K00021]
  PATHWAY   hsa00900(3156)  Terpenoid backbone biosynthesis
METABOLISM  Enzyme: CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]
            Transporter: SLCO1B1 [HSA:10599]
INTERACTION CYP inhibition: CYP2C9 [HSA:1559]
            Transporter inhibition: ABCB11 [HSA:8647]
STR_MAP     map07024  HMG-CoA reductase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C10 LIPID MODIFYING AGENTS
               C10A LIPID MODIFYING AGENTS, PLAIN
                C10AA HMG CoA reductase inhibitors
                 C10AA04 Fluvastatin
                  D00892  Fluvastatin sodium (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Dyslipidemics, HMG CoA Reductase Inhibitors
               Fluvastatin
                D00892  Fluvastatin sodium (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               218  Hyperlipidemia agents
                2189  Others
                 D00892  Fluvastatin sodium (JAN/USP)
            Drug groups [BR:br08330]
             Hypolipidemic agent
              DG01946  Hypolipidemic agent
               DG01660  HMG-CoA reductase inhibitor
                DG00354  Fluvastatin
                 D00892  Fluvastatin sodium
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               DG00354  Fluvastatin
                D00892  Fluvastatin sodium
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00354  Fluvastatin
                 D00892  Fluvastatin sodium
             Metabolizing enzyme inhibitor
              DG01643  CYP2C9 inhibitor
               DG00354  Fluvastatin
                D00892  Fluvastatin sodium
             Transporter substrate
              DG02856  SLCO1B1 substrate
               DG00354  Fluvastatin
                D00892  Fluvastatin sodium
             Transporter inhibitor
              DG02882  ABCB11 inhibitor
               DG00354  Fluvastatin
                D00892  Fluvastatin sodium
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG01946  Hypolipidemic agent
               D00892  Fluvastatin sodium
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Oxidoreductases (EC1)
               Dehydrogenases
                HMGCR
                 D00892  Fluvastatin sodium (JAN/USP) &lt;JP/US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00892
             Drug transporters
              D00892
            Drug groups [BR:br08330]
             Hypolipidemic agent
              DG01946  Hypolipidemic agent
               DG01660  HMG-CoA reductase inhibitor
                DG00354  Fluvastatin
             Metabolizing enzyme substrate
              DG01642  CYP2C9 substrate
               DG00354  Fluvastatin
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00354  Fluvastatin
             Metabolizing enzyme inhibitor
              DG01643  CYP2C9 inhibitor
               DG00354  Fluvastatin
             Transporter substrate
              DG02856  SLCO1B1 substrate
               DG00354  Fluvastatin
             Transporter inhibitor
              DG02882  ABCB11 inhibitor
               DG00354  Fluvastatin
DBLINKS     CAS: 93957-55-2
            PubChem: 7847956
            ChEBI: 5137
            LigandBox: D00892
            NIKKAJI: J556.740H
ATOM        31
            1   Z   Na   25.8336  -11.8516 #+
            2   C8y C    12.5783  -14.7270
            3   C8x C    12.5783  -16.1297
            4   C8x C    13.7706  -16.8311
            5   C8y C    15.0330  -16.1297
            6   C8x C    15.0330  -14.7270
            7   C8x C    13.7706  -14.0257
            8   X   F    11.3861  -14.0257
            9   C8y C    16.2253  -16.8311
            10  C8y C    16.7162  -18.1636
            11  C8y C    18.0488  -18.1636
            12  N4y N    18.4696  -16.8311
            13  C8y C    17.3474  -15.9895
            14  C8x C    16.0149  -19.3559
            15  C8x C    16.7162  -20.6183
            16  C8x C    18.1189  -20.6183
            17  C8x C    18.8203  -19.3559
            18  C2b C    17.3474  -14.5868
            19  C1a C    20.9243  -16.8311
            20  C1c C    19.7320  -16.1297
            21  C1a C    19.7320  -14.7270
            22  C2b C    18.5397  -13.8854
            23  C1c C    18.5397  -12.4828
            24  C1b C    19.7320  -11.7814
            25  C1c C    20.9243  -12.4828
            26  C1b C    22.1165  -11.7814
            27  C6a C    23.3088  -12.4828
            28  O6a O    24.5011  -11.7814 #-
            29  O6a O    23.3088  -13.8854
            30  O1a O    17.3474  -11.7814
            31  O1a O    20.9243  -13.8854
BOND        32
            1     2   3 2
            2     3   4 1
            3     4   5 2
            4     5   6 1
            5     6   7 2
            6     2   7 1
            7     2   8 1
            8     5   9 1
            9     9  10 1
            10   10  11 1
            11   11  12 1
            12   12  13 1
            13    9  13 2
            14   10  14 2
            15   14  15 1
            16   15  16 2
            17   16  17 1
            18   11  17 2
            19   13  18 1
            20   19  20 1
            21   12  20 1
            22   20  21 1
            23   18  22 2
            24   22  23 1
            25   23  24 1
            26   24  25 1
            27   25  26 1
            28   26  27 1
            29   27  28 1
            30   27  29 2
            31   23  30 1 #Down
            32   25  31 1 #Up
///
